Skip to content

Actualités & publications

MID’s participation in the 2026 JECB

MID soutient les Journées d’Échanges en Chirurgie Bariatrique 2026

MID will be present at the Journées d’Échanges en Chirurgie Bariatrique (JECB) on November 5 and 6, 2026. A key event for healthcare professionals involved in obesity management and the evolution of surgical practices.

MID, a partner for innovation in bariatric surgery
At MID (Medical Innovation Développement), we believe that medical innovation is deeply rooted in listening to healthcare professionals, sharing knowledge, and collaborating with surgical teams. With this in mind, we are pleased to support the 2026 Journées d’Échanges en Chirurgie Bariatrique, which will bring together bariatric and metabolic surgery specialists on November 5 and 6 to discuss current and future challenges in obesity care. Our participation in this event reflects our commitment to healthcare professionals and our desire to contribute to the development of medical solutions that meet the demands of surgical practice.

The 2026 JECB: a major event in bariatric surgery
The Journées d’Échanges en Chirurgie Bariatrique is a major event for professionals involved in obesity surgery. The congress focuses on dialogue, interactivity, and topics directly related to daily practice. It allows surgeons and medical teams to share their experiences, compare approaches, and explore developments in their specialty.

The 2026 edition will highlight several major topics:

  • Artificial intelligence and the digital transition in surgery.
  • The complementarity between bariatric surgery and GLP-1 treatments.
  • The management of complex complications.
  • Advanced surgical techniques and innovations.
  • The evolution of practices surrounding sleeve gastrectomy.

These themes perfectly illustrate the transformations taking place in bariatric surgery and the importance of close collaboration among healthcare stakeholders.

MID: French expertise serving healthcare professionals
Since 1999, MID has built its expertise in designing, developing, and marketing medical devices, particularly for bariatric surgery. Our know-how is based on a deep understanding of surgical teams’ needs and a continuous approach to innovation. We provide dedicated solutions for bariatric and metabolic surgery, including:

  • MIDBAND™, an adjustable gastric band.
  • MIDCAL™, a gastric calibration ring.
  • MIDSLEEVE™, a calibration tube for sleeve gastrectomy.
  • MID-TUBE™ and MIDSOND, devices dedicated to calibration and surgical practices.

Through our presence at the 2026 JECB, we look forward to continuing our dialogue with healthcare professionals, gaining a better understanding of their expectations, and contributing to a collective effort to improve practices.

Meet MID at the 2026 Journées d’Échanges en Chirurgie Bariatrique
We are pleased to support this scientific gathering and to connect with key players in bariatric and metabolic surgery to discuss their experiences, projects, and the evolution of their specialty.

Dates: November 5 and 6, 2026
Event: Journées d’Échanges en Chirurgie Bariatrique (JECB)

To discover the full congress program, please visit the official website:
https://www.journees-echanges-bariatrique.com/programme

MID would like to thank the organizers and healthcare professionals who help make this event a major highlight for sharing and medical innovation.
MID – Innovation for Surgery

MIDBAND™ and MIDCAL™ are Class II.b medical devices manufactured by MEDICAL INNOVATION DEVELOPPEMENT (MID) SAS – CE No. 0476. These devices are implants intended for the surgical treatment of obesity. Only experienced practitioners belonging to a dedicated team fully qualified in obesity surgery are authorized to use the MID100-M and MID180 devices. 
MID-TUBE™, MIDSLEEVE™, and MIDSOND are Class II.a devices manufactured by MEDICAL INNOVATION DEVELOPPEMENT (MID) SAS – CE No. 0459. These devices are orogastric tubes intended for the surgical treatment of obesity. Only experienced practitioners belonging to a dedicated team fully qualified in obesity surgery are authorized to use the MID13X, MID160, and MID012 devices.